{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T19:08:40Z","timestamp":1769886520120,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2025ZNSFSC1726"],"award-info":[{"award-number":["2025ZNSFSC1726"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009731","name":"Sichuan Provincial Youth Science and Technology Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bmcl.2025.130500","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:30:24Z","timestamp":1765413024000},"page":"130500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis and biological evaluation of coumarin-based HDAC6 inhibitors for the treatment of ulcerative colitis"],"prefix":"10.1016","volume":"132","author":[{"given":"Xiang","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhen","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangxing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuling","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengfan","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2025.130500_bb0005","first-page":"340","article-title":"Ulcerative colitis","author":"Ungaro","year":"2016","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.bmcl.2025.130500_bb0010","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jama.2023.15389","article-title":"Ulcerative colitis in adults: a review","volume":"330","author":"Gros","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130500_bb0015","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00535-018-1439-1","article-title":"Evidence-based clinical practice guidelines for inflammatory bowel disease","volume":"53","author":"Matsuoka","year":"2018","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.bmcl.2025.130500_bb0020","first-page":"1","volume":"6","author":"Kobayashi","year":"2020","journal-title":"Ulcerative colitis Nature Reviews Disease Primers"},{"issue":"18","key":"10.1016\/j.bmcl.2025.130500_bb0025","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMra1102942","article-title":"MEDICAL PROGRESS ulcerative colitis","volume":"365","author":"Danese","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2025.130500_bb0030","article-title":"Novel therapies for immune-mediated inflammatory diseases: what can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn\u2019s disease and ulcerative colitis?","author":"Baker","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"18","key":"10.1016\/j.bmcl.2025.130500_bb0035","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1056\/NEJMoa1513248","article-title":"Ozanimod induction and maintenance treatment for ulcerative colitis","volume":"374","author":"Sandborn","year":"2016","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130500_bb0040","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1080\/13543784.2018.1492547","article-title":"Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials","volume":"27","author":"D\u2019Amico","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"issue":"23","key":"10.1016\/j.bmcl.2025.130500_bb0045","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmcl.2025.130500_bb0050","article-title":"Loss of response to anti-TNFs: definition, epidemiology, and management. Clinical and translational","volume":"7(1).doi:10.1038\/ctg.2015.63","author":"Roda","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bmcl.2025.130500_bb0055","first-page":"122","article-title":"Synthesis and biological evaluation of novel 4-Arylaminoquinolines derivatives as EGFR\/HDAC inhibitors","author":"Yao","year":"2025","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130500_bb0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2217\/epi.14.69","article-title":"Histone deacetylase 6 in health and disease","volume":"7","author":"Seidel","year":"2015","journal-title":"Epigenomics"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130500_bb0065","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-018-0654-9","article-title":"Histone deacetylase 6 in cancer","volume":"11","author":"Li","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"6","key":"10.1016\/j.bmcl.2025.130500_bb0070","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1021\/jm502011f","article-title":"Design and synthesis of orally bioavailable Aminopyrrolidinone histone deacetylase 6 inhibitors","volume":"58","author":"Lin","year":"2015","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130500_bb0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/emmm.201201923","article-title":"Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer\u2019s disease","volume":"5","author":"Govindarajan","year":"2012","journal-title":"EMBO Molecular Medicine"},{"key":"10.1016\/j.bmcl.2025.130500_bb0080","first-page":"201","article-title":"ROS-responsive thioketal nanoparticles delivering system for targeted ulcerative colitis therapy with potent HDAC6 inhibitor, tubastatin a","author":"Shrestha","year":"2024","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130500_bb0085","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/1759-7714.12974","article-title":"Targeted inhibition of histone deacetylase 6 in inflammatory diseases","volume":"10","author":"Ran","year":"2019","journal-title":"Thoracic Cancer"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130500_bb0090","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/jpet.116.236711","article-title":"An HDAC6 inhibitor confers protection and selectively inhibits B-cell infiltration in DSS-induced colitis in mice","volume":"360","author":"Do","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmcl.2025.130500_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-10518-z","article-title":"HDAC6 regulates NF-\u03baB signalling to control chondrocyte IL-1-induced MMP and inflammatory gene expression","author":"Barter","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.bmcl.2025.130500_bb0100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.intimp.2013.03.016","article-title":"Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects","volume":"16","author":"Vishwakarma","year":"2013","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130500_bb0105","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.ajpath.2020.08.013","article-title":"Inhibition of histone deacetylase 6 by Tubastatin a attenuates the Progress of osteoarthritis via improving mitochondrial function","volume":"190","author":"Zheng","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bmcl.2025.130500_bb0110","article-title":"The histone deacetylase family: structural features and application of combined computational methods","volume":"17(5).doi:10.3390\/ph17050620","author":"Curcio","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"3","key":"10.1016\/j.bmcl.2025.130500_bb0115","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.pharmthera.2014.04.004","article-title":"Histone deacetylase inhibitor (HDACI) mechanisms of action: emerging insights","volume":"143","author":"Bose","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmcl.2025.130500_bb0120","first-page":"52","article-title":"From natural products to HDAC inhibitors: an overview of drug discovery and design strategy","author":"Qiu","year":"2021","journal-title":"Bioorg Med Chem"},{"issue":"4","key":"10.1016\/j.bmcl.2025.130500_bb0125","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1021\/acs.jmedchem.5b01342","article-title":"Discovery of selective histone deacetylase 6 inhibitors using the quinazoline as the cap for the treatment of Cancer","volume":"59","author":"Yang","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130500_bb0130","article-title":"2-methylquinazoline derivative F7 as a potent and selective HDAC6 inhibitor protected against rhabdomyolysis-induced acute kidney injury","author":"Liu","year":"2019","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.bmcl.2025.130500_bb0135","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1007\/s00044-012-0321-6","article-title":"Coumarin: a potential nucleus for anti-inflammatory molecules","volume":"22","author":"Bansal","year":"2012","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmcl.2025.130500_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26020422","article-title":"Coumarin derivatives in inflammatory bowel disease","author":"Di Stasi","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmcl.2025.130500_bb0145","first-page":"41","article-title":"Design, synthesis and molecular modeling studies of novel mesalamine linked coumarin for treatment of inflammatory bowel disease","author":"Rath","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"issue":"12","key":"10.1016\/j.bmcl.2025.130500_bb0150","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1021\/acs.jmedchem.6b00158","article-title":"Design, synthesis, and evaluation of in vitro and in vivo anticancer activity of 4-substituted coumarins: a novel class of potent tubulin polymerization inhibitors","volume":"59","author":"Cao","year":"2016","journal-title":"J Med Chem"},{"issue":"26","key":"10.1016\/j.bmcl.2025.130500_bb0155","doi-asserted-by":"crossref","first-page":"12472","DOI":"10.1073\/pnas.91.26.12472","article-title":"Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase","volume":"91","author":"Szabo","year":"1995","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmcl.2025.130500_bb0160","first-page":"13(4)","article-title":"Study of the Metabolic Profiles of \u201cIndazole-3-Carboxamide\u201d and \u201cIsatin Acyl Hydrazone\u201d (OXIZID) Synthetic Cannabinoids in a Human Liver Microsome Model Using UHPLC-QE Orbitrap MS","author":"Xiang","year":"2023","journal-title":"Metabolites"},{"issue":"9","key":"10.1016\/j.bmcl.2025.130500_bb0165","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nchembio.2134","article-title":"Histone deacetylase 6 structure and molecular basis of catalysis and inhibition","volume":"12","author":"Hai","year":"2016","journal-title":"Nat Chem Biol"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25004093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25004093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T05:00:21Z","timestamp":1769835621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25004093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":33,"alternative-id":["S0960894X25004093"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130500","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of coumarin-based HDAC6 inhibitors for the treatment of ulcerative colitis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130500","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130500"}}